High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods

US2023248973A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023248973-A1
Application numberUS-202318131760-A
CountryUS
Kind codeA1
Filing dateApr 6, 2023
Priority dateJan 19, 2017
Publication dateAug 10, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 1.5 kHz to 100 kHz.

First claim

Opening claim text (preview).

1 - 30 . (canceled) 31 . A method of treating a patient having diabetic neuropathy, via spinal cord stimulation, comprising: at least partially in response to the patient having a symptom of tingling caused by the patient's diabetic neuropathy, programming a signal generator to deliver a non-paresthesia producing electrical signal to the patient's spinal cord via at least one implanted signal delivery element, wherein the non-paresthesia producing electrical signal has a frequency of 10 kHz, a pulse width in a pulse width range of from about 30 microseconds to about 35 microseconds, and an amplitude in an amplitude range of from 0.5 mA to 7 mA, wherein the non-paresthesia producing electrical signal at least partially eliminates the tingling caused by the diabetic neuropathy without causing a side-effect of signal-induced paresthesia. 32 . The method of claim 31 wherein the at least one implanted signal delivery element is positioned in the patient's thoracic vertebral region. 33 . The method of claim 31 wherein the at least one implanted signal delivery element is positioned in the patient's thoracic vertebral region between T8 and T12, inclusive. 34 . The method of claim 31 wherein the at least one implanted signal delivery element is positioned in the patient's epidural space. 35 . The method of claim 31 wherein the tingling is in the patient's foot. 36 . The method of claim 31 wherein the patient also has foot pain caused by the patient's diabetic neuropathy, and wherein the non-paresthesia producing electrical signal also reduces the patient's foot pain without causing the side-effect of signal-induced paresthesia. 37 . The method of claim 36 wherein programming the signal generator is performed at least partially in response to the patient having foot pain. 38 . A method of treating a patient having diabetic neuropathy, via spinal cord stimulation, comprising: at least partially in response to the patient having a symptom of tingling associated with the patient's diabetic neuropathy, programming a signal generator to deliver a non-paresthesia producing electrical signal to the patient's spinal cord via at least one implanted signal delivery element, wherein the non-paresthesia-producing electrical signal has a frequency in a frequency range of from about 5 kHz to about 15 kHz, a pulse width in a pulse width range of from about 20 microseconds to about 40 microseconds, and an amplitude in an amplitude range of from 0.5 mA to 10 mA, wherein the non-paresthesia producing electrical signal at least partially eliminates the tingling associated with the diabetic neuropathy without causing a side-effect of signal-induced paresthesia. 39 . The method of claim 38 wherein the at least one implanted signal delivery element is positioned in the patient's epidural space at a thoracic vertebral region between T8 and T12, inclusive. 40 . The method of claim 38 wherein the non-paresthesia producing electrical signal has a duty cycle of between about 10% and about 100%. 41 . The method of claim 40 wherein the non-paresthesia producing electrical signal has a duty cycle of about 14%. 42 . The method of claim 38 wherein the tingling is concentrated in one or both of the patient's feet and/or one or both of the patient's hands. 43 . The method of claim 38 wherein the signal generator is implanted. 44 . A method of treating a patient having diabetic neuropathy, via spinal cord stimulation, comprising: at least partially in response to the patient having tingling associated with the patient's diabetic neuropathy, programming a signal generator to deliver a non-paresthesia producing electrical signal to the patient's spinal cord via at least one implanted signal delivery element, wherein the non-paresthesia producing electrical signal has a frequency in a frequency range of from about 1.5 kHz to about 20 kHz, a pulse width in a pulse width range of from about 20 microseconds to about 100 microseconds, and an amplitude in an amplitude range of from 0.5 mA to 10 mA, wherein the non-paresthesia producing electrical signal at least partially eliminates the tingling associated with the diabetic neuropathy without causing a side-effect of signal-induced paresthesia. 45 . The method of claim 44 wherein the at least one implanted signal delivery element is positioned at a thoracic vertebral region between T8 and T12, inclusive. 46 . The method of claim 44 wherein the non-paresthesia producing electrical signal has a duty cycle of between about 10% and about 100%. 47 . The method of claim 46 wherein the non-paresthesia producing electrical signal has a duty cycle of about 14%. 48 . The method of claim 44 wherein the tingling is in one or both of the patient's feet. 49 . The method of claim 44 wherein the signal generator is implanted. 50 . The method of claim 44 wherein the signal generator is external.

Assignees

Inventors

Classifications

  • Spinal stimulation · CPC title

  • Frequency · CPC title

  • characterised by the communication link, e.g. acoustic or tactile · CPC title

  • Current (A61N1/3616 takes precedence) · CPC title

  • Pulse width or duty cycle · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023248973A1 cover?
High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient…
Who is the assignee on this patent?
Nevro Corp
What technology area does this patent fall under?
Primary CPC classification A61N1/36062. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Aug 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).